What question did this study set out to answer?

This research aims to develop a multi-epitope mRNA vaccine to enhance CD8+ T cell responses against HIV-1.

Processing-Optimized Multi-Epitope mRNA Vaccine Enhances HIV-1—Specific CD8+ T Cells 2258806

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial shows enhanced HIV-1 specific CD8+ T cell responses in transgenic mice and PBMCs, suggesting improved immunity.

This research aims to develop a multi-epitope mRNA vaccine to enhance CD8+ T cell responses against HIV-1.
Generated mRNAs with optimized tandem CD8+ epitopes and flanking sequences.
Immunized HLA-A*02:01 transgenic mice and analyzed T-cell responses through ELISpot and flow cytometry.
Conducted in vitro boosting assays with PBMCs from individuals with HIV-1.]
HLA-A*02:01 mice showed a 3.4-fold increase in epitope-specific CD8+ T cells (p=0.0137).
With TLR8L, frequency increased to 4.7-fold (p=0.0273).
The percentage of cells co-expressing granzyme B and perforin increased from 40.8% to 80.5% with TLR8L (p=0.0137).

Nogimori et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark